Checkpoint Therapeutics Inc banner

Checkpoint Therapeutics Inc
F:CZTA

Watchlist Manager
Checkpoint Therapeutics Inc Logo
Checkpoint Therapeutics Inc
F:CZTA
Watchlist
Price: 3.755 EUR Market Closed
Market Cap: €140.4m

Wall St Price Targets

CZTA Price Targets Summary
Checkpoint Therapeutics Inc

There are no price targets for CZTA.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Checkpoint Therapeutics Inc Competitors:
Price Targets
PTEN
Patterson-UTI Energy Inc
15% Upside
FAST
Fastenal Co
4% Upside
CFFN
Capitol Federal Financial Inc
7% Upside

Revenue
Forecast

-40% / Year
Past Growth
247% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
-40% / Year
Past Growth
247% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been -40%. The projected CAGR for the next 8 years is 247%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Checkpoint Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Checkpoint Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CZTA's stock price target?
Not Available

CZTA does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Checkpoint Therapeutics Inc?
Projected CAGR
247%

Over the last 8 years, the compound annual growth rate for Revenue has been -40%. The projected CAGR for the next 8 years is 247%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett